{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:58:39Z","timestamp":1792112319001,"version":"4.4.0"},"reference-count":35,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10,1]]},"abstract":"\n OBJECTIVES:<\/jats:title>\n The objective of this study was to examine factors that are associated with aggression that is responsive versus refractory to individualized optimization of stimulant monotherapy among children with attention-deficit\/hyperactivity disorder (ADHD).<\/jats:p>\n <\/jats:sec>\n \n METHODS:<\/jats:title>\n Children who were aged 6 to 13 years and had ADHD, either oppositional defiant disorder or conduct disorder, significant aggressive behavior, and a history of insufficient response to stimulants completed an open stimulant monotherapy optimization protocol. Stimulant titration with weekly assessments of behavior and tolerability identified an optimal regimen for each child. Families also received behavioral therapy. Parents completed the Retrospective-Modified Overt Aggression Scale (R-MOAS) at each visit. Children were classified as having stimulant-refractory aggression on the basis of R-MOAS ratings and clinician judgment. Differences that pertained to treatment, demographic, and psychopathology between groups with stimulant monotherapy\u2013responsive and \u2013refractory aggression were evaluated.<\/jats:p>\n <\/jats:sec>\n \n RESULTS:<\/jats:title>\n Aggression among 32 (49.3%) of 65 children was reduced sufficiently after stimulant dosage adjustment and behavioral therapy to preclude adjunctive medication. Those who responded to stimulant monotherapy were more likely to benefit from the protocol's methylphenidate preparation (once-daily, triphasic release), showed a trend for lower average dosages, and received fewer behavioral therapy sessions than did children with stimulant-refractory aggression. Boys, especially those with higher ratings of baseline aggression and of depressive and manic symptoms, more often exhibited stimulant-refractory aggression.<\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS:<\/jats:title>\n Among children whose aggressive behavior develops in the context of ADHD and of oppositional defiant disorder or conduct disorder, and who had insufficient response to previous stimulant treatment in routine clinical care, systematic, well-monitored titration of stimulant monotherapy often culminates in reduced aggression that averts the need for additional agents.<\/jats:p>\n <\/jats:sec>","DOI":"10.1542\/peds.2010-0086","type":"journal-article","created":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T23:58:08Z","timestamp":1284422288000},"page":"e796-e806","source":"Crossref","is-referenced-by-count":96,"title":["Stimulant-Responsive and Stimulant-Refractory Aggressive Behavior Among Children With ADHD"],"prefix":"10.1542","volume":"126","author":[{"given":"Joseph C.","family":"Blader","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Science, Stony Brook University School of Medicine, State University of New York, Stony Brook, New York;"},{"name":"Division of Psychiatry Research, Zucker Hillside Hospital, North Shore\u2013LIJ Health System, Glen Oaks, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Pliszka","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Jensen","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota; and"},{"name":"REACH Institute, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina R.","family":"Schooler","sequence":"additional","affiliation":[{"name":"Division of Psychiatry Research, Zucker Hillside Hospital, North Shore\u2013LIJ Health System, Glen Oaks, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Kafantaris","sequence":"additional","affiliation":[{"name":"Division of Psychiatry Research, Zucker Hillside Hospital, North Shore\u2013LIJ Health System, Glen Oaks, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2010,10,1]]},"reference":[{"issue":"6","key":"2021121010252195100_B1","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2004-2560","article-title":"Treatment of attention-deficit\/hyperactivity disorder: overview of the evidence","volume":"115","author":"Brown","year":"2005","journal-title":"Pediatrics"},{"issue":"5","key":"2021121010252195100_B2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00004583-199905000-00011","article-title":"Stimulant medications","volume":"38","author":"Greenhill","year":"1999","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"12","key":"2021121010252195100_B3","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archpsyc.1997.01830240023003","article-title":"Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder","volume":"54","author":"Klein","year":"1997","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"2021121010252195100_B4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00004583-200203000-00004","article-title":"Psychopharmacology and aggression: I\u2014a meta-analysis of stimulant effects on overt\/covert aggression: related behaviors in ADHD","volume":"41","author":"Connor","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"2021121010252195100_B5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/archpsyc.63.6.679","article-title":"National trends in the outpatient treatment of children and adolescents with antipsychotic drugs","volume":"63","author":"Olfson","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"2021121010252195100_B6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/01.chi.0000157543.74509.c8","article-title":"Trends in the use of typical and atypical antipsychotics in children and adolescents","volume":"44","author":"Patel","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"2021121010252195100_B7","doi-asserted-by":"crossref","first-page":"w770","DOI":"10.1377\/hlthaff.28.5.w770","article-title":"Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges","volume":"28","author":"Crystal","year":"2009","journal-title":"Health Aff (Millwood)"},{"issue":"16","key":"2021121010252195100_B8","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2009.1549","article-title":"Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents","volume":"302","author":"Correll","year":"2009","journal-title":"JAMA"},{"issue":"11","key":"2021121010252195100_B9","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1176\/appi.ajp.2008.08050756","article-title":"Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study","volume":"165","author":"Sikich","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"3","key":"2021121010252195100_B10","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1089\/cap.2004.14.372","article-title":"Second-generation antipsychotic medications in children and adolescents","volume":"14","author":"Cheng-Shannon","year":"2004","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"6","key":"2021121010252195100_B11","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/01.chi.0000215326.51175.eb","article-title":"The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit\/hyperactivity disorder (ADHD)","volume":"45","author":"Pliszka","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"2021121010252195100_B12","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4088\/JCP.v67n0516","article-title":"Juvenile maladaptive aggression: a review of prevention, treatment, and service configuration and a proposed research agenda","volume":"67","author":"Connor","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"2021121010252195100_B13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/chi.0b013e31802f1454","article-title":"Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies","volume":"46","author":"Jensen","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2021121010252195100_B14","first-page":"467","article-title":"Aggression in children: an integrative approach","volume-title":"Lewis' Textbook of Child and Adolescent Psychiatry","author":"Blader","year":"2007","edition":"4th ed"},{"issue":"10","key":"2021121010252195100_B15","first-page":"36","article-title":"How to reduce mania risk when prescribing stimulants: evidence-based hierarchy helps when bipolar and ADHD symptoms overlap","volume":"4","author":"Dubovsky","year":"2005","journal-title":"Curr Psychiatry"},{"issue":"7","key":"2021121010252195100_B16","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.biopsych.2005.05.037","article-title":"Heterogeneity of irritability in attention-deficit\/hyperactivity disorder subjects with and without mood disorders","volume":"58","author":"Mick","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"3","key":"2021121010252195100_B17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1176\/appi.ajp.160.3.430","article-title":"Defining clinical phenotypes of juvenile mania","volume":"160","author":"Leibenluft","year":"2003","journal-title":"Am J Psychiatry"},{"issue":"12","key":"2021121010252195100_B18","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1176\/appi.ajp.2009.09020233","article-title":"Adjunctive divalproex sodium vs. placebo for children with ADHD and aggression refractory to stimulant monotherapy","volume":"166","author":"Blader","year":"2009","journal-title":"Am J Psychiatry"},{"issue":"12","key":"2021121010252195100_B19","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/CHI.0b013e3181bc730d","article-title":"Characteristics of placebo responders in pediatric clinical trials of attention-deficit\/hyperactivity disorder","volume":"48","author":"Newcorn","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"7","key":"2021121010252195100_B20","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00004583-199707000-00021","article-title":"Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity","volume":"36","author":"Kaufman","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"2021121010252195100_B21","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1176\/appi.ajp.157.5.818","article-title":"Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design","volume":"157","author":"Donovan","year":"2000","journal-title":"Am J Psychiatry"},{"key":"2021121010252195100_B22","article-title":"Conners' Rating Scales\u2013Revised","author":"Conners","year":"1997"},{"key":"2021121010252195100_B23","article-title":"Children's Depression Rating Scale\u2013Revised","author":"Poznanski","year":"1995"},{"key":"2021121010252195100_B24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"issue":"2","key":"2021121010252195100_B25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1542\/peds.86.2.184","article-title":"Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation","volume":"86","author":"Barkley","year":"1990","journal-title":"Pediatrics"},{"issue":"10","key":"2021121010252195100_B26","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/00004583-199610000-00017","article-title":"Medication treatment strategies in the MTA study: Relevance to clinicians and researchers","volume":"35","author":"Greenhill","year":"1996","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"7","key":"2021121010252195100_B27","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.chi.0000128791.10014.ac","article-title":"Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment","volume":"43","author":"Abikoff","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"12","key":"2021121010252195100_B28","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archpsyc.56.12.1073","article-title":"A 14-month randomized clinical trial of treatment strategies for attention-deficit\/hyperactivity disorder","volume":"56","author":"MTA Cooperative Group","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"2021121010252195100_B29","article-title":"COPE: The Community Parent Education Program: A School Based Family Systems Oriented Workshop for Parents of Children With Disruptive Behavior Disorders","author":"Cunningham","year":"2000"},{"issue":"6","key":"2021121010252195100_B30","doi-asserted-by":"crossref","DOI":"10.1542\/peds.107.6.e105","article-title":"Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings","volume":"107","author":"Pelham","year":"2001","journal-title":"Pediatrics"},{"issue":"2","key":"2021121010252195100_B31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1037\/1082-989X.1.2.170","article-title":"Meta-analysis of experiments with matched groups or repeated measures designs","volume":"1","author":"Dunlap","year":"1996","journal-title":"Psychol Methods"},{"key":"2021121010252195100_B32","volume-title":"Concerta\u00ae (Methylphenidate HCl) Extended-Release Tablets: Full Prescribing Information","author":"McNeil Pediatrics","year":"2009"},{"issue":"1","key":"2021121010252195100_B33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/CHI.0b013e31818b1c8f","article-title":"Stimulant dosing for children with ADHD: a medical claims analysis","volume":"48","author":"Olfson","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"2021121010252195100_B34","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1542\/peds.108.4.1033","article-title":"Clinical practice guideline: treatment of the school-aged child with attention-deficit\/hyperactivity disorder","volume":"108","author":"American Academy of Pediatrics, Subcommittee on Attention-Deficit\/Hyperactivity Disorder and Committee on Quality Improvement","year":"2001","journal-title":"Pediatrics"},{"issue":"4","key":"2021121010252195100_B35","first-page":"1248","article-title":"Improving mental health services in primary care: reducing administrative and financial barriers to access and collaboration [published correction appears in Pediatrics. 2009;123(6):1611","volume":"123","author":"American Academy of Child and Adolescent Psychiatry Committee on Health Care Access and Economics, American Academy of Pediatrics Task Force on Mental Health","year":"2009","journal-title":"Pediatrics"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/126\/4\/e796\/1058446\/zpe0101000e796.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/126\/4\/e796\/1058446\/zpe0101000e796.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T04:40:56Z","timestamp":1685767256000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/126\/4\/e796\/65626\/Stimulant-Responsive-and-Stimulant-Refractory"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,1]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2010,10,1]]},"published-print":{"date-parts":[[2010,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2010-0086","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717957882.793462190","asserted-by":"object"}]},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,1]]}}}